The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

Eitemau Tebyg

• Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
  gan: Coles, A, et al.
  Cyhoeddwyd: (1999)
• Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
  gan: Coles, A, et al.
  Cyhoeddwyd: (1999)
• Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
  gan: Cox, A, et al.
  Cyhoeddwyd: (2005)
• Monoclonal antibodies in multiple sclerosis treatment: current and future steps
  gan: Claire L. Helliwell, et al.
  Cyhoeddwyd: (2009-07-01)
• Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
  gan: Bindon, C, et al.
  Cyhoeddwyd: (1985)